Komori
Other Disclosures4559ZERIA PHARMACEUTICAL CO.,LTD.Pharmaceuticals

Notice of the New Launch of the “IONA F RJ Derma” Series

ZERIA PHARMACEUTICAL CO.,LTD. has launched 4 new products in the IONA F skincare brand: a booster serum, medicated lotion, medicated emulsion and medicated cream. The products will be sold at drugstores, pharmacies and online retailers nationwide.

Worth reading
63In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
4
Product
Wording
Definitive
How definitive the wording is.

Announced details

IONA F RJ Derma Repair Boost SerumIONA F RJ Derma Medicated Wrinkle White LotionIONA F RJ Derma Medicated Wrinkle White MilkIONA F RJ Derma Medicated Wrinkle White Cream
Applicable field (uses covered by this announcement)

Skincare and high-performance anti-aging skincare

Launch date1 September 2026 (already launched)
What the company reported numerically
Quantitative Effects

Royal jelly contains more than 40 nutrients. Other quantitative effects are not disclosed.

Relationship between the counterparty and the company
ZERIA PHARMACEUTICAL CO.,LTD.4559
Relationship with the Company

ZERIA PHARMACEUTICAL CO.,LTD. is the launching company, while イオナ インターナショナル株式会社 is the manufacturer and distributor. Capital and personnel relationships are not disclosed.

Counterpartyイオナ インターナショナル株式会社

Only its role as the manufacturer and distributor is disclosed. Other company information is not disclosed.

Offering price

Repair Boost Serum: ¥5,500 (including tax)

Medicated Wrinkle White Lotion: ¥4,950 (including tax)

Medicated Wrinkle White Milk: ¥5,280 (including tax)

Medicated Wrinkle White Cream: ¥5,500 (including tax)

The company does not address Contract Value / Impact on Business Performance.

Announced details
ItemDetails
Names of Products / Services CoveredIONA F RJ Derma Repair Boost Serum, IONA F RJ Derma Medicated Wrinkle White Lotion, IONA F RJ Derma Medicated Wrinkle White Milk, IONA F RJ Derma Medicated Wrinkle White Cream
Counterpartyイオナ インターナショナル株式会社
Counterparty overviewOnly its role as the manufacturer and distributor is disclosed. Other company information is not disclosed.
Relationship with the CompanyZERIA PHARMACEUTICAL CO.,LTD. is the launching company, while イオナ インターナショナル株式会社 is the manufacturer and distributor. Capital and personnel relationships are not disclosed.
Offering priceRepair Boost Serum: ¥5,500 (including tax), Medicated Wrinkle White Lotion: ¥4,950 (including tax), Medicated Wrinkle White Milk: ¥5,280 (including tax), Medicated Wrinkle White Cream: ¥5,500 (including tax)
Launch date1 September 2026 (already launched)
Applicable areaSkincare and high-performance anti-aging skincare
Quantitative EffectsRoyal jelly contains more than 40 nutrients. Other quantitative effects are not disclosed.
Items this document does not state (10)
Contract ValueContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleUsage historyImpact on Business PerformanceSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To provide high-performance anti-aging skincare based on the benefits of nature and advanced dermatological science by combining royal jelly with proprietary ingredients known for long-lasting moisturization.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of the New Launch of the “IONA F RJ Derma” Series | ZERIA PHARMACEUTICAL CO.,LTD. (4559) timely disclosure | Komori